Comprehensive and detailed guide on ‘Tirzépatide and Chronic Kidney Disease: Précautions for Use’: sourced medical information, practical recommendations, and expert advice for patients undergoing GLP-1 treatment. Understanding the Stakes The topic addressed in this article – tirzépatide and chronic kidney disease: précautions for use – is a major concern for … Read more
Complète and detailed guide on ‘Mounjaro and Fertility: What You Need to Know Before Pregnancy’: sourced medical information, practical recommendations, and expert advice for patients undergoing GLP-1 treatment. Understanding the Stakes The topic addressed in this article – Mounjaro and Fertility: What You Need to Know Before Pregnancy – … Read more
Comprehensive and detailed guide on ‘GLP-1 and Polycystic Ovary Syndrome (PCOS)’: sourced medical information, practical recommendations, and expert advice for patients undergoing GLP-1 treatment. Understanding the challenges The topic addressed in this article – GLP-1 and Polycystic Ovary Syndrome (PCOS) – is a major concern for patients undergoing … Read more
Tirzépatide significantly improves the lipid profile: lowering LDL, reducing triglycerides, and increasing HDL. Impact of tirzépatide on LDL cholestérol Tirzépatide reduces LDL-cholestérol by 5 to 10% on average in clinical trials. Although this reduction is modest compared to statins, it adds to the effects of the latter. … Read more
Mounjaro (tirzepatide) reduces blood pressure by an average of 5 to 8 mmHg, a clinically significant benefit for obese hypertensive patients. Hypertension and obesity: a vicious cycle. Obesity is a major risk factor for high blood pressure. Each 10 kg of excess weight increases systolic blood pressure by 3 to … Read more
Obesity promotes metabolic syndrome. GLP-1 agonists like tirzepatide simultaneously correct several components. Understanding Metabolic Syndrome Metabolic syndrome is defined by the presence of at least 3 of the following 5 criteria: waist circumference greater than 94 cm (men) or 80 cm (women), triglycerides greater than 1.5 g/L, HDL-cholesterol less than … Read more
The dual benefit of tirzepatide in patients with type 2 diabetes: glycemic control and simultaneous weight loss. Tirzepatide: the first dual GLP-1/GIP agonist. Mounjaro (tirzepatide) is the first medication to simultaneously activate GLP-1 and GIP receptors, two essential incretin hormones in glucose regulation and energy metabolism. … Read more
Guide to understanding and interpreting your blood test results during tirzepatide treatment: blood glucose, lipids, liver, kidneys, and deficiencies. Glycemic markers Under tirzepatide, glycemic markers show favorable changes. Fasting blood glucose (normal: 0.70 to 1.10 g/L) decreases thanks to the drug’s action on insulin secretion and sensitivity … Read more
A complete list to prepare for your appointment with an obesity specialist: documents, questions, blood tests, and goals to define. Why prepare for your consultation? An obesity consultation lasts an average of 20 to 30 minutes. This time is precious and must be optimized. Patients who arrive prepared receive more precise answers, faster therapeutic adjustments … Read more
Learn everything about the maximum Mounjaro dose of 15 mg: for which patients, when to use it, demonstrated efficacy, and managing side effects at high doses. The 15 mg dose in clinical trials The 15 mg dose represents the maximum authorized dose of Mounjaro (tirzepatide). In the SURMOUNT-1 trial, published in … Read more
Guide to managing the transition from 2.5 mg to 5 mg of Mounjaro (tirzepatide): when to increase, expected effects, anti-nausea strategies, and signals requiring postponement. Why transition from 2.5 mg to 5 mg? The 2.5 mg dose is the initiation dose for Mounjaro, designed to allow the body to adapt to tirzepatide. After … Read more
Your first month on Mounjaro week by week: what to expect in terms of weight, appetite, side effects, and body changes with tirzepatide. Week 1: the start of the journey. Your first Mounjaro injection marks the beginning of a gradual biological process. At 2.5 mg (initiation dose), the effects are generally subtle. … Read more